SS-31 Side Effects: 7 Things to Watch For (and How to Manage Them)

SS-31 at a glance:

• Drug class: Metabolic / longevity research peptide
• Route: subcutaneous injection in research
• Typical frequency: no established human regimen
• Half-life: typically short systemically

Side effects are the single biggest reason people quit SS-31 during the first eight weeks. Most of them are predictable and most of them improve. Knowing which is which up front makes the difference.

Common Side Effects of SS-31

The side effects most often reported with SS-31:

• Limited human data — monitor and discuss with your clinician if it persists or worsens.

These tend to be dose-related. They are most prominent during dose escalation and typically improve once the body adapts to a steady dose.

Serious Risks

Less common but important:

• Unknown long-term effects — see the prescribing information for full risk language for details. Notify your clinician promptly if relevant symptoms develop.

How to Manage Common Side Effects

Track what you feel. Side effects are easier to discuss when you have a record of when they appear and how severe they are.

Don't change the dose on your own. Many side effects improve with time at a steady dose; stopping and restarting often resets the adaptation period.

Stay hydrated and eat regularly. Generic advice that nonetheless prevents many otherwise-avoidable side-effect calls.

Communicate with your clinician. Most side effects have a management strategy; the worst outcomes happen when people stop the drug silently and don't get the next-step plan.

For dose-titration questions, see our SS-31 dosage guide.

Side Effects vs. Withdrawal Effects

It's worth distinguishing between side effects (from taking the drug) and withdrawal or rebound effects (from stopping it). For SS-31, the most relevant rebound concern is compound-specific — see the prescribing information.

When to Stop and Call Someone

These symptoms warrant prompt clinical evaluation:

• Severe abdominal pain (especially radiating to the back) — possible pancreatitis
• Vision changes
• Signs of allergic reaction (hives, throat tightness, difficulty breathing)
• Severe vomiting or dehydration
• Persistent symptoms that worsen rather than improve

Side Effects in Context

Most people who take SS-31 experience some side effects. Most of those are tolerable and improve with time. The decision to continue is a balance between benefit and tolerance, made together with a clinician.

For people weighing whether SS-31 is the right fit, our SS-31 results page covers the upside.

Bottom Line

Most SS-31 side effects improve with time at a steady dose. The minority that don't usually have a management strategy worth trying before stopping the drug.

Frequently Asked Questions

Related Reading

• Is SS-31 Right for You? An Evidence-Based Breakdown
• NAD+ 101: A Plain-English Guide for 2026
• NAD+ Side Effects Decoded: What's Normal vs. What Isn't
• What Results Should You Expect from NAD+? A Practical Guide
• The Real NAD+ Price Tag in 2026 — With and Without Insurance
• NAD+ Cycle Guide: Published Research vs. Online Protocols

Sources

• Lee C et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis. Cell Metabolism 2015;21:443.
• Birk AV et al. The Mitochondrial-Targeted Peptide SS-31 Selectively Improves Mitochondrial Function. JASN 2013;24:1250.

This page is informational only and is not medical advice. Stop SS-31 and seek medical attention if you experience severe symptoms.